The treatment of Kyrle's disease: a systematic review
暂无分享,去创建一个
[1] Laura E. Abate,et al. A systematic review of evidence‐based treatments for prurigo nodularis , 2019, Journal of the American Academy of Dermatology.
[2] H. Dao,et al. Chronic Pruritus: A Review of Neurophysiology and Associated Immune Neuromodulatory Treatments. , 2018, Skin therapy letter.
[3] J. Pinto,et al. Kyrle's disease associated with HIV infection, diabetes, and chronic kidney disease , 2018, Indian journal of pathology & microbiology.
[4] T. Ruzicka,et al. Clinical and molecular characterization and response to acitretin in three families with Sjögren‐Larsson syndrome , 2018, International journal of dermatology.
[5] P. Gisondi,et al. Kyrle’s disease effectively treated with oral isotretinoin , 2018, The Journal of dermatological treatment.
[6] Akhila Lakshmikantha,et al. Kyrle’s disease: a cutaneous manifestation of diabetes mellitus , 2017, BMJ Case Reports.
[7] D. Paton. Dupilumab: human monoclonal antibody against IL-4Rα for moderate to severe atopic dermatitis. , 2017, Drugs of today.
[8] Y. Matsuzaki,et al. Successful treatment of Kyrle disease with narrowband ultraviolet B , 2017, The Journal of dermatology.
[9] S. Shimada,et al. Efficacy of topical tacrolimus for treating Kyrle's disease , 2017, The Journal of dermatology.
[10] Connie M. Rhee,et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] R. Verma,et al. Kyrle's Disease Presenting in an Extensive Distribution along Lines of Blaschko , 2015, Indian Journal of Dermatology.
[12] N. Diwan,et al. Kyrle's disease in a patient of diabetes mellitus and chronic renal failure on dialysis , 2015, Journal of family medicine and primary care.
[13] S. Jee,et al. Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis. , 2014, Journal of the American Academy of Dermatology.
[14] A. Metin,et al. Clinicopathological features of 25 patients with acquired perforating dermatosis. , 2013, EJD. European journal of dermatology.
[15] F. Persechino,et al. Kyrle's Disease: Treatment with Minocycline and Topic Tacalcitol , 2013 .
[16] T. Tsai,et al. Kyrle’s disease successfully treated with allopurinol , 2011, International Journal of Dermatology.
[17] H. Törmä. Regulation of keratin expression by retinoids , 2011, Dermato-endocrinology.
[18] K. Hari Kumar,et al. Acquired perforating dermatoses in patients with diabetic kidney disease on hemodialysis , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.
[19] T. Tsuda,et al. Tetracyclines Modulate Protease-Activated Receptor 2-Mediated Proinflammatory Reactions in Epidermal Keratinocytes , 2009, Antimicrobial Agents and Chemotherapy.
[20] Qiang Zhou,et al. Structures and biological functions of IL-31 and IL-31 receptors. , 2008, Cytokine & growth factor reviews.
[21] I. Slim,et al. Regression of skin lesions of Kyrle's disease with metronidazole in a diabetic patient. , 2007, The Journal of infection.
[22] F. Port,et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] S. G. Shimada,et al. Scratching behavior in mice induced by the proteinase-activated receptor-2 agonist, SLIGRL-NH2. , 2006, European journal of pharmacology.
[24] M. Falagas,et al. Regression of skin lesions of Kyrle's disease with clindamycin: implications for an infectious component in the etiology of the disease. , 2005, The Journal of infection.
[25] C. Ihm,et al. Acquired Perforating Dermatosis in Patients with Chronic Renal Failure and Diabetes Mellitus , 2004, Journal of Korean medical science.
[26] Thomas A. Luger,et al. Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin , 2003, The Journal of Neuroscience.
[27] M. Nilles,et al. Erworbene reaktiv perforierende Dermatose bei Psoriasis vulgaris , 2001 .
[28] C. Morton,et al. Acquired perforating dermatosis in a British dialysis population , 1996, The British journal of dermatology.
[29] R. Pisharody,et al. Kyrle's disease : a cutaneous marker of renal disorder. , 1996, Indian Journal of Dermatology, Venereology and Leprology.
[30] K. Lloyd,et al. Kyrle's disease. Effectively treated with isotretinoin. , 1993, The Journal of the Florida Medical Association.
[31] M. Melton,et al. Perforating folliculitis in association with hemodialysis , 1982, The American Journal of dermatopathology.
[32] V. S. Constantine,et al. Kyrle's Disease: II. Histopathologic Findings in Five Cases and Review of the Literature , 1968 .
[33] V. S. Constantine,et al. Kyrle's Disease: I. Clinical Findings in Five Cases and Review of Literature , 1968 .
[34] Connie M. Rhee,et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] C. Massone,et al. Allopurinol in the treatment of acquired reactive perforating collagenosis* , 2013, Anais brasileiros de dermatologia.
[36] P. Frosch,et al. Successful treatment of acquired reactive perforating collagenosis with doxycycline. , 2002, Acta dermato-venereologica.